ArticleScientific reports2025
Optimizing YOLOv11 for automated classification of breast cancer in medical images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A novel serum metabolite classifier for identifying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics and machine learning.BMC gastroenterology · 2026Article
- Automated classification of osteoporotic vertebral compression fractures in DR images based on improved YOLO26n-seg.Frontiers in medicine · 2026Article
- Multidimensional feature fusion in longitudinal physical examination data: a machine learning framework for classification of type 2 diabetes.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Breast cancer diagnosis via histopathology image analysis is a complex and subjective process. While deep learning has emerged as a powerful tool for automation, achieving high accuracy across diverse cancer subtypes and magnification levels remains a significant challenge. This paper introduces a Novel-MultiScaleAttention model, an advanced architecture designed to capture discriminative features across multiple morphological scales in histopathology images. We conduct a comprehensive evaluation on two publicly available benchmark datasets: a large binary classification dataset (Breast Cancer - v1, N = 16,652 images, M_100X vs. B_100X) and the more complex 8-class subset of the BreakHis dataset (N = 4,914 images). Our proposed model is rigorously compared against state-of-the-art baselines, including YOLO11base, ResNet18, EfficientNet, and MobileNet. The results demonstrate that our model achieves superior performance, attaining a top accuracy of 0.9808 and a macro AUC of 0.9978 on the binary dataset. On the challenging 8-class dataset, it achieves a leading accuracy of 0.9363 and a macro AUC of 0.9956, outperforming other models in overall discriminative ability. Furthermore, a detailed computational analysis reveals a favorable performance-efficiency trade-off. An in-depth error analysis identifies specific misclassification patterns, aligning with known diagnostic challenges in pathology. The findings confirm that the Novel-MultiScaleAttention model provides an accurate framework for breast cancer histopathology image classification, demonstrating strong generalization capability across two distinct datasets and showing potential to serve as a valuable decision-support tool in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.